Karyopharm Therapeutics Inc (KPTI)
$0.72 -$0.01 (-1.02%) 12:13 PM 12/12/24
NASDAQ | $USD | BiotechnologyStock Data
-
Market Cap
$96.27M -
Day's Range
$0.72 - $0.75 -
Volume
862,974 -
52 Week Low / High
$0.62 - $1.95 -
PE Ratio
- -
PEG Ratio
-0.15 -
Dividend Frequency
-
KPTI's Dividend
Hypothetical 10k Investment Jan 1, 2020
- Capital Growth
- Dividend Return to Date
- Dividend Payout year Est.
- Expenses
- Total Return
- Total Return %
Analyists Ranking
- 2
- Strong Buy
- 4
- Buy
- 1
- Hold
- 0
- Sell
- 0
- Strong Sell
- $6.67
- Target Price
Company News
-
Karyopharm Announces Preliminary Unaudited 2023 Revenue and 2024 Objectives — Jan 8th, 2024
– Accelerating Innovation and Growth Strategy with Top-Line Data Readouts Expected in 2H 2024 and 2025 from Three Pivotal Phase 3 Studies Evaluating Selinexor in Multiple Myeloma, Endometrial Cancer and Myelofibrosis – – Preliminary Unaudited Full Year 2023 Total Revenue and U.S. XP...
|
Portfolio
$5,000/year
Goal: $10,000/year
Comprised of 1 portfolios
$